Form D · Biotechnology
Milestone Gynomics Corp.
Cupertino, CA · CIK 0002096871
Offering snapshot reported Nov 14, 2025 · SEC filing
- Reported sold
- $34K Indefinite offering
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 2, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 14, 2025 | Initial | $34,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-564111
Simple Agreement for Future Equity (SAFE)
Source: Form D, filed Nov 14, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Gregory Daryl Miles | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
20425 Via Paviso Apt. D27
Cupertino, CA, 95014
Cupertino, CA, 95014